Measuring the HIV/AIDS epidemic: approaches and challenges. - Wikidata - awgldk - TriplyDB

Measuring the HIV/AIDS epidemic: approaches and challenges.

Measuring the HIV/AIDS epidemic: approaches and challenges.

http://www.wikidata.org/entity/Q30386305

about

Inter-laboratory assessment of a prototype multiplex kit for determination of recent HIV-1 infection Molecular characterization of ambiguous mutations in HIV-1 polymerase gene: implications for monitoring HIV infection status and drug resistance Assessing network scale-up estimates for groups most at risk of HIV/AIDS: evidence from a multiple-method study of heavy drug users in Curitiba, Brazil Use of a high resolution melting (HRM) assay to compare gag, pol, and env diversity in adults with different stages of HIV infection Rethinking HIV prevalence determination in developing countries.Beyond surveillance: a role for respondent-driven sampling in implementation science.Is back-projection methodology still relevant for estimating HIV incidence from national surveillance data?Pregnancy does not affect HIV incidence test results obtained using the BED capture enzyme immunoassay or an antibody avidity assay.A comparison of two measures of HIV diversity in multi-assay algorithms for HIV incidence estimation.BED estimates of HIV incidence: resolving the differences, making things simpler.Epidemiologic approaches to global health.Evaluation of dried blood spots with a multiplex assay for measuring recent HIV-1 infection Biomarker-based HIV incidence in a community sample of men who have sex with men in Paris, France.Analysis of HIV using a high resolution melting (HRM) diversity assay: automation of HRM data analysis enhances the utility of the assay for analysis of HIV incidence.Effect of natural and ARV-induced viral suppression and viral breakthrough on anti-HIV antibody proportion and avidity in patients with HIV-1 subtype B infection.The undiagnosed HIV epidemic in France and its implications for HIV screening strategies.Health care system and policy factors influencing engagement in HIV medical care: piecing together the fragments of a fractured health care delivery system.Estimated incidence and genotypes of HIV-1 among pregnant women in central Brazil.Development of methods for cross-sectional HIV incidence estimation in a large, community randomized trial Performance of a limiting-antigen avidity enzyme immunoassay for cross-sectional estimation of HIV incidence in the United States.Trends in socioeconomic inequalities in HIV prevalence among young people in seven countries in eastern and southern Africa.Using estimation and projection package and Spectrum for Jamaica's national HIV estimates and targets.Sample size methods for estimating HIV incidence from cross-sectional surveys.Mean Recency Period for Estimation of HIV-1 Incidence with the BED-Capture EIA and Bio-Rad Avidity in Persons Diagnosed in the United States with Subtype B.Mapping HIV prevalence using population and antenatal sentinel-based HIV surveys: a multi-stage approach Performance of Bio-Rad and Limiting Antigen Avidity Assays in Detecting Recent HIV Infections Using the Quebec Primary HIV-1 Infection Cohort.Factors associated with incorrect identification of recent HIV infection using the BED capture immunoassay.Specificity of four laboratory approaches for cross-sectional HIV incidence determination: analysis of samples from adults with known nonrecent HIV infection from five African countries.HIV incidence among non-pregnant women living in selected rural, semi-rural and urban areas in KwaZulu-Natal, South Africa.Comparison of cross-sectional HIV incidence assay results from dried blood spots and plasma.Data quality shortcomings with the US HIV/AIDS surveillance system.Lower-sensitivity and avidity modifications of the vitros anti-HIV 1+2 assay for detection of recent HIV infections and incidence estimation.Use of a multifaceted approach to analyze HIV incidence in a cohort study of women in the United States: HIV Prevention Trials Network 064 Study HIV incidence determination in the United States: a multiassay approach.A Method to Estimate the Size and Characteristics of HIV-positive Populations Using an Individual-based Stochastic Simulation Model Prevalence and risk factors of latent Tuberculosis among adolescents in rural Eastern Uganda.Changing epidemiology of HIV in Mumbai: an application of the Asian epidemic model Estimation of HIV incidence using multiple biomarkers.Community viral load, antiretroviral therapy coverage, and HIV incidence in India: a cross-sectional, comparative study.Differential specificity of HIV incidence assays in HIV subtypes A and D-infected individuals from Rakai, Uganda.

P2860

Q28534491-181518AF-A8FC-477B-8BA2-24A62082FDD8 Q28534497-00401A78-310C-4D58-B992-53FE7104ECB3 Q28743152-D163F26C-F95F-4035-83D1-CB172752923B Q28743210-3739DAD0-CAF5-43BD-ACEA-A731EAECFD22 Q30366288-0B693A35-8BAD-42FA-8FD8-DD466576535D Q30432413-053FDF9E-562E-4FDD-8A1C-3B9C8741525E Q30572713-B77A150D-249B-4CD0-A379-ABA1049FB554 Q33719217-4D6A4899-F8D5-4698-B6FA-E1F6AFFA0212 Q33812743-30A71347-1538-48CA-9056-885E18C4B39C Q34123863-36B5CF27-16DC-4B8F-814A-F85031EED325 Q34138802-FA5F9312-186B-4FD6-A5D5-D6CD1518B07D Q34214893-79B95BF8-5C76-4737-A3CB-F98875265862 Q34328348-5CE334FF-2FF7-4214-9261-1972C510EB16 Q34512320-58A06C41-2AF7-4293-B19C-2FDF4A6D61F5 Q34598155-CF3C233B-EFA4-4CCC-997E-1682A40B3B83 Q34676429-FAF09B5F-6819-4DB7-BEAE-F91903D70BE0 Q35019905-21C14FE5-FFCA-4449-81F0-CA7254B8DF8B Q35041199-3999602F-D491-42AA-A66C-57109F3E78F1 Q35043592-B3643457-BACA-4BF1-AEA5-53E84B6F7FA4 Q35080053-1CA24B65-EC86-440C-AE28-943BBE49714B Q35202695-F41811DB-8C15-44EC-91D2-46D27A60C2FB Q35214998-FD211E4E-A842-47D3-A678-37CB787F0AD7 Q35753750-F1C6908E-E961-4B1A-9BF1-FE296CADA4B0 Q35985816-686A547E-D5E7-4E22-BE98-659F68A9AFA3 Q36019471-9E4DE6F2-3474-4A1B-8752-08665D686BC0 Q36029177-F0BCDCE9-B844-41F9-8571-BE2C61BD529C Q36102525-2CEA3FE0-7EE6-4C2A-8D22-782C81649F52 Q36250409-B8910B5C-3E3D-489E-8D26-4AD91A8AA0A3 Q36279405-78E89B9E-EA54-4509-AEEC-B4050D3737F8 Q36288430-6B9D2B50-7E7C-4614-B606-3F6B0EF92E1F Q36367245-20CE36EF-E8E3-46C7-8E83-7AEDA346641C Q36414171-3B7C7F1D-74AA-4AA6-BFA4-74034D5B838C Q36495534-35590660-1222-47A3-B110-640EBC87707C Q36495553-64546B55-B31C-4F55-B6B6-ECE30E36F8B5 Q36523426-54D07DED-A3F3-433C-B76D-F4EE8390617E Q36612697-8EABBA89-3AF0-49BC-8FB5-0550EE968F96 Q36648147-DEFE0C8F-AE36-44E0-8047-4551C027ACC4 Q36764936-151A9744-0A5B-46B9-AFFC-63AE73BDBF2F Q36889651-50F89F21-BE8F-4813-8C7F-EFE4B631452D Q37025719-31406B77-A6FD-4A03-8609-FA7581FF5C98

P2860

Measuring the HIV/AIDS epidemic: approaches and challenges.

http://www.wikidata.org/entity/Q30386305

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Measuring the HIV/AIDS epidemic: approaches and challenges.

@ast

Measuring the HIV/AIDS epidemic: approaches and challenges.

@en

type

label

Measuring the HIV/AIDS epidemic: approaches and challenges.

@ast

Measuring the HIV/AIDS epidemic: approaches and challenges.

@en

prefLabel

Measuring the HIV/AIDS epidemic: approaches and challenges.

@ast

Measuring the HIV/AIDS epidemic: approaches and challenges.

@en

P1433

Q30386305-8615B01B-CE26-4825-92CC-E6F31037F733

P1476

Q30386305-3068AB7A-D173-4A3E-B579-0E6F5DAB30F5

P2860

Q30386305-02CD0A37-160A-495B-AF50-E74A1FA177F4

Q30386305-06091492-6077-4A8A-8B89-6B5FA0F83029

Q30386305-14D7B0C4-BFCE-4B77-832A-CDEF6013EC67

Q30386305-1A4E3912-A8E9-4D7B-AA83-366E52BE1285

Q30386305-2381F00F-C7D2-41C2-B0E6-C30E5F4308E0

Q30386305-2752AF52-6335-463C-9095-CCA18FDA96E2

Q30386305-2C6500E7-7701-4D0C-A0A9-5BA0E9982717

Q30386305-2E981AA8-EB1B-43FE-9080-E5FBBB357FE8

Q30386305-318FF9AA-5241-4730-B9B4-13021F19BA5B

Q30386305-3AA6CF1D-ABBE-47B8-9AAF-15D9663DDF34

P304

Q30386305-3AD5E1D0-58ED-49A2-8B46-B1589066FBCB

P31

Q30386305-B60568DA-EFFE-4515-91A3-9F435E9C44FA

P356

Q30386305-01BD5540-6DF1-49DA-B5F7-0D2CCC34F298

P478

Q30386305-112EAE74-32F8-402B-A3E0-C9060B318E06

P50

Q30386305-A9F8FAB3-A5E2-4F2D-962A-D8FA61D962A9

P577

Q30386305-71E5E09F-4496-4EF9-9026-A1D34DB19B58

P5875

Q30386305-A4395BE4-1882-4542-B93C-25F8CB9548C5

P698

Q30386305-3CDC0635-0F90-4B7B-98C2-49AD96EC1865

P921

Q30386305-20E49208-C8DD-4C0A-9B1B-B4A9DF0614FB

P356

P1433

Epidemiologic Reviews

P1476

Measuring the HIV/AIDS epidemic: approaches and challenges.

@en

P2860

Estimating the global burden of HIV/AIDS: what do we really know about the HIV pandemic?

Estimating HIV incidence rates from age prevalence data in epidemic situations.

Estimating HIV incidence and detection rates from surveillance data.

Improved data, methods and tools for the 2007 HIV and AIDS estimates and projections.

Comparison of adult HIV prevalence from national population-based surveys and antenatal clinic surveillance in countries with generalised epidemics: implications for calibrating surveillance data.

Joint analysis of HIV and AIDS surveillance data in back-calculation.

Confidence intervals for biomarker-based human immunodeficiency virus incidence estimates and differences using prevalent data.

Estimating incidence from prevalence in generalised HIV epidemics: methods and validation.

HIV prevalence in voluntary counseling and testing centers compared with national HIV serosurvey data in Uganda.

Estimating HIV incidence in the United States from HIV/AIDS surveillance data and biomarker HIV test results.

P304

26-37

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/EPIREV/MXQ002

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-03-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41760615

http://www.w3.org/2001/XMLSchema#string

P698

20203104

http://www.w3.org/2001/XMLSchema#string

P921